Article summary
Plus: RAND survey shows that nearly a quarter of U.S. adults support legal use of psilocybin mushrooms; Reunion Neuroscience gets FDA Breakthrough Therapy status for shorter acting psychedelic
Continue to the original publication for the complete article.